Structural and Functional Disruption of Vascular Smooth Muscle Cells in a Transgenic Mouse Model of Amyloid Angiopathy
Open Access
- 31 March 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (3) , 1065-1071
- https://doi.org/10.1016/s0002-9440(10)64053-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathwayNeurobiology of Aging, 2000
- Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease modelAnnals of Neurology, 2000
- Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathwayNeurobiology of Aging, 2000
- Toxicity of Dutch (E22Q) and Flemish (A21G) Mutant Amyloid β Proteins to Human Cerebral Microvessel and Aortic Smooth Muscle CellsStroke, 2000
- Characteristics of thein VitroVasoactivity of β-Amyloid PeptidesExperimental Neurology, 1998
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- β-Amyloid-mediated vasoactivity and vascular endothelial damageNature, 1996
- Altered cleavage and secretion of a recombinant β–APP bearing the Swedish familial Alzheimer's disease mutationNature Genetics, 1994
- Microvasculature in Brain Biopsy Specimens from Patients with Alzheimer's Disease: An Immunohistochemical and Ultrastructural StudyUltrastructural Pathology, 1994
- Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological studyAnnals of Neurology, 1991